ProGnosis Biotech presented its AOAC PTM Certified histamine testing technologies and hygiene monitoring solutions, supporting seafood and aquaculture professionals with faster, clearer and more practical quality control decisions.
ProGnosis Biotech participated in Aquaculture UK 2026, presenting its AOAC PTM Certified histamine testing technologies and hygiene monitoring solutions to seafood and aquaculture professionals focused on strengthening quality control, food safety and operational performance.
As aquaculture and seafood operations continue to evolve, quality assurance can no longer remain a final checkpoint. It needs to be part of daily production, helping teams detect risks earlier, respond faster and maintain better control across the value chain.
At this year’s event, ProGnosis Biotech reinforced a clear position: seafood safety depends not only on accurate testing, but also on tools that can support real production needs. A central focus of the company’s presence was histamine control, one of the most time-sensitive challenges in fish and seafood quality management. In high-pressure production environments, delays in testing can directly affect product release, logistics, compliance and consumer safety. For quality teams, speed, simplicity and reliability are essential when decisions need to be made while they are still operationally relevant.
ProGnosis Biotech showcased its AOAC PTM-Certified Histamine Testing portfolio, including ELISA and Lateral Flow methods designed to support both quantitative analysis and rapid routine screening. These solutions reflect the company’s commitment to diagnostics that work beyond controlled laboratory conditions, helping seafood teams simplify preparation, reduce workflow complexity and make confident quality control decisions.
The company also highlighted its Hygiene Monitoring technologies for surface and water samples, addressing another critical layer of seafood safety. In aquaculture and seafood processing environments, hygiene verification is central to prevention, process control and consistent production standards. By presenting histamine testing together with hygiene monitoring, ProGnosis Biotech demonstrated a broader approach to seafood safety that supports proactive risk management rather than reactive problem-solving.
Discussions at Aquaculture UK 2026 confirmed a clear industry need for solutions that combine scientific reliability with practical application. Seafood and aquaculture professionals are looking for tools that can support daily production demands, reduce complexity and strengthen confidence across critical control points.
For ProGnosis Biotech, this participation was not simply about showcasing technologies It was an opportunity to contribute to a wider industry conversation on how seafood safety systems can become faster, more preventive and more closely connected to the realities of modern production. As the dialogue continues beyond the event, ProGnosis Biotech remains committed to supporting seafood and aquaculture teams with diagnostic solutions that help them act earlier, control risk more effectively and protect quality where it matters most.

